{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:53:33Z","timestamp":1792000413045,"version":"4.4.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T00:00:00Z","timestamp":1679270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T00:00:00Z","timestamp":1679270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Jin Chen","award":["82073462"],"award-info":[{"award-number":["82073462"]}]},{"name":"Jin Chen","award":["82073462"],"award-info":[{"award-number":["82073462"]}]},{"name":"Jin Chen","award":["82073462"],"award-info":[{"award-number":["82073462"]}]},{"name":"Jin Chen","award":["82073462"],"award-info":[{"award-number":["82073462"]}]},{"name":"Jin Chen","award":["82073462"],"award-info":[{"award-number":["82073462"]}]},{"name":"Jin Chen","award":["82073462"],"award-info":[{"award-number":["82073462"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The present meta-analysis aimed to elucidate the association of Beh\u00e7et\u2019s disease (BD) with the risk of metabolic syndrome (MetS) and its components. Observational cohort studies were searched from the Embase, Web of Science, Medline, and Cochrane Library databases. The primary outcome was the association of BD with the risk of MetS and its relevant components. Effect estimates with odds ratios (ORs) were pooled using either the random-effects or fixed-effects models, according to heterogeneity. Leave-one-out sensitivity analyses were used to determine the stability of the results. Twenty-three studies, comprising 42,834 patients with BD, were included. Overall, a significant association between BD and the risk of MetS was found (pooled OR 2.26; 95% confidence interval [CI] 1.61\u20133.17;\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.0001). Among the components of MetS, significant associations were found between BD and diabetes mellitus (OR 1.21; 95% CI 1.10\u20131.33;\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.0001), BD and hypertension (OR 1.39; 95% CI 1.13\u20131.70;\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.002), and BD and dyslipidemia (OR 1.21; 95% CI 1.01\u20131.45;\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.04). Our study indicated an association between BD and the risk of MetS and some of its components (diabetes mellitus, hypertension, and dyslipidemia). Physician should consider these associations so that specific treatments are available for patients with comorbidities. Moreover, patients with BD should regularly monitor their blood pressure, fasting plasma glucose, and blood lipid levels.\n                  <\/jats:p>","DOI":"10.1007\/s10238-023-01044-x","type":"journal-article","created":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T06:02:58Z","timestamp":1679292178000},"page":"2855-2866","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Association of Beh\u00e7et\u2019s disease with the risk of metabolic syndrome and its components: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"23","author":[{"given":"Tingqiao","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangmei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,20]]},"reference":[{"key":"1044_CR1","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jaut.2009.02.011","volume":"32","author":"D Mendes","year":"2009","unstructured":"Mendes D, Correia M, Barbedo M, et al. Beh\u00e7et\u2019s disease\u2014a contemporary review. J Autoimmun. 2009;32:178\u201388. https:\/\/doi.org\/10.1016\/j.jaut.2009.02.011.","journal-title":"J Autoimmun"},{"key":"1044_CR2","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1097\/RHU.0b013e31828639e0","volume":"19","author":"JB Kim","year":"2013","unstructured":"Kim JB, Kim S, Lee T, et al. Colchicine-induced rhabdomyolysis caused by interaction with clarithromycin in a patient with Behcet disease. J Clin Rheumatol. 2013;19:108\u20139. https:\/\/doi.org\/10.1097\/RHU.0b013e31828639e0.","journal-title":"J Clin Rheumatol"},{"key":"1044_CR3","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/jdv.14601","volume":"32","author":"YB Lee","year":"2018","unstructured":"Lee YB, Lee SY, Choi JY, et al. Incidence, prevalence, and mortality of Adamantiades-Beh\u00e7et\u2019s disease in Korea: a nationwide, population-based study (2006\u20132015). J Eur Acad Dermatol Venereol. 2018;32:999\u20131003. https:\/\/doi.org\/10.1111\/jdv.14601.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1044_CR4","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1111\/j.1365-2133.2007.08116.x","volume":"157","author":"E Alpsoy","year":"2007","unstructured":"Alpsoy E, Donmez L, Onder M, et al. Clinical features and natural course of Beh\u00e7et\u2019s disease in 661 cases: a multicentre study. Br J Dermatol. 2007;157:901\u20136. https:\/\/doi.org\/10.1111\/j.1365-2133.2007.08116.x.","journal-title":"Br J Dermatol"},{"key":"1044_CR5","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/echo.12524","volume":"31","author":"H Farouk","year":"2014","unstructured":"Farouk H. Beh\u00e7et\u2019s disease, echocardiographers, and cardiac surgeons: together is better. Echocardiography. 2014;31:783\u20137. https:\/\/doi.org\/10.1111\/echo.12524.","journal-title":"Echocardiography"},{"key":"1044_CR6","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s10067-013-2205-7","volume":"32","author":"Y Fei","year":"2013","unstructured":"Fei Y, Li X, Lin S, et al. Major vascular involvement in Beh\u00e7et\u2019s disease: a retrospective study of 796 patients. Clin Rheumatol. 2013;32:845\u201352. https:\/\/doi.org\/10.1007\/s10067-013-2205-7.","journal-title":"Clin Rheumatol"},{"key":"1044_CR7","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00296-016-3435-1","volume":"37","author":"DP Misra","year":"2017","unstructured":"Misra DP, Shenoy SN. Cardiac involvement in primary systemic vasculitis and potential drug therapies to reduce cardiovascular risk. Rheumatol Int. 2017;37:151\u201367. https:\/\/doi.org\/10.1007\/s00296-016-3435-1.","journal-title":"Rheumatol Int"},{"key":"1044_CR8","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1097\/00005792-200301000-00006","volume":"82","author":"E Kural-Seyahi","year":"2003","unstructured":"Kural-Seyahi E, Fresko I, Seyahi N, et al. The long-term mortality and morbidity of Beh\u00e7et syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore). 2003;82:60\u201376. https:\/\/doi.org\/10.1097\/00005792-200301000-00006.","journal-title":"Medicine (Baltimore)"},{"key":"1044_CR9","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.autrev.2011.11.026","volume":"11","author":"PM de Chambrun","year":"2012","unstructured":"de Chambrun PM, Wechsler B, Geri G, Cacoub P, Saadoun D. New insights into the pathogenesis of Beh\u00e7et\u2019s disease. Autoimmun Rev. 2012;11:687\u201398. https:\/\/doi.org\/10.1016\/j.autrev.2011.11.026.","journal-title":"Autoimmun Rev"},{"key":"1044_CR10","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.dsx.2018.11.055","volume":"13","author":"K Kalan Farmanfarma","year":"2019","unstructured":"Kalan Farmanfarma K, Kaykhaei MA, Adineh HA, Mohammadi M, Dabiri S, Ansari-Moghaddam A. Prevalence of metabolic syndrome in Iran: a meta-analysis of 69 studies. Diabetes Metab Syndr. 2019;13:792\u20139. https:\/\/doi.org\/10.1016\/j.dsx.2018.11.055.","journal-title":"Diabetes Metab Syndr"},{"key":"1044_CR11","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/S0140-6736(05)66378-7","volume":"365","author":"RH Eckel","year":"2005","unstructured":"Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365:1415\u201328. https:\/\/doi.org\/10.1016\/S0140-6736(05)66378-7.","journal-title":"Lancet"},{"key":"1044_CR12","doi-asserted-by":"publisher","first-page":"703","DOI":"10.2174\/1871530319666191008170409","volume":"20","author":"S Choudhary","year":"2020","unstructured":"Choudhary S, Pradhan D, Pandey A, et al. The association of metabolic syndrome and psoriasis: a systematic review and meta-analysis of observational study. Endocr Metab Immune Disord Drug Targets. 2020;20:703\u201317. https:\/\/doi.org\/10.2174\/1871530319666191008170409.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"1044_CR13","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1111\/ijd.14500","volume":"58","author":"K Phan","year":"2019","unstructured":"Phan K, Charlton O, Smith SD. Hidradenitis suppurativa and metabolic syndrome\u2014systematic review and adjusted meta-analysis. Int J Dermatol. 2019;58:1112\u20137. https:\/\/doi.org\/10.1111\/ijd.14500.","journal-title":"Int J Dermatol"},{"key":"1044_CR14","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s40257-013-0034-8","volume":"14","author":"B Yal\u00e7\u0131n","year":"2013","unstructured":"Yal\u00e7\u0131n B, G\u00fcr G, Art\u00fcz F, All\u0131 N. Prevalence of metabolic syndrome in Beh\u00e7et disease: a case-control study in Turkey. Am J Clin Dermatol. 2013;14:421\u20135. https:\/\/doi.org\/10.1007\/s40257-013-0034-8.","journal-title":"Am J Clin Dermatol"},{"issue":"Suppl 45","key":"1044_CR15","first-page":"S118","volume":"25","author":"A Oguz","year":"2007","unstructured":"Oguz A, Dogan EG, Uzunlulu M, Oguz FM. Insulin resistance and adiponectin levels in Beh\u00e7et\u2019s syndrome. Clin Exp Rheumatol. 2007;25(Suppl 45):S118\u20139.","journal-title":"Clin Exp Rheumatol"},{"key":"1044_CR16","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.clindermatol.2017.09.016","volume":"36","author":"S Seremet","year":"2018","unstructured":"Seremet S, Gurel MS. Miscellaneous skin disease and the metabolic syndrome. Clin Dermatol. 2018;36:94\u2013100. https:\/\/doi.org\/10.1016\/j.clindermatol.2017.09.016.","journal-title":"Clin Dermatol"},{"key":"1044_CR17","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. Anal Obs Stud Epidemiol (Moose) Group JAMA. 2000;283:2008\u201312. https:\/\/doi.org\/10.1001\/jama.283.15.2008.","journal-title":"Anal Obs Stud Epidemiol (Moose) Group JAMA"},{"key":"1044_CR18","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLOS Med. 2009;6:e1000097. https:\/\/doi.org\/10.1371\/journal.pmed.1000097.","journal-title":"PLOS Med"},{"key":"1044_CR19","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603\u20135. https:\/\/doi.org\/10.1007\/s10654-010-9491-z.","journal-title":"Eur J Epidemiol"},{"key":"1044_CR20","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/ije\/dyn188","volume":"38","author":"J Brok","year":"2009","unstructured":"Brok J, Thorlund K, Wetterslev J, Gluud C. Apparently conclusive meta-analyses may be inconclusive\u2014trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses. Int J Epidemiol. 2009;38:287\u201398. https:\/\/doi.org\/10.1093\/ije\/dyn188.","journal-title":"Int J Epidemiol"},{"key":"1044_CR21","first-page":"471","volume":"316","author":"P Langhorne","year":"1998","unstructured":"Langhorne P. Bias in meta-analysis detected by a simple, graphical test. Prospectively identified trials could be used for comparison with meta-analyses. BMJ. 1998;316:471.","journal-title":"BMJ"},{"key":"1044_CR22","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1684\/ejd.2014.2490","volume":"25","author":"FC Gul","year":"2015","unstructured":"Gul FC, Cicek D, Kaman D, Demir B, Nazik H. Changes of serum lipocalin-2 and retinol binding protein-4 levels in patients with psoriasis and Beh\u00e7et\u2019s disease. Eur J Dermatol. 2015;25:195\u20137. https:\/\/doi.org\/10.1684\/ejd.2014.2490.","journal-title":"Eur J Dermatol"},{"key":"1044_CR23","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ejr.2016.11.001","volume":"39","author":"I El-Gazzar","year":"2017","unstructured":"El-Gazzar I, El-Dakrony A-H, Sayed S, et al. Clinical significance of metabolic syndrome and carotid intima-media thickness in Beh\u04abet\u2019s disease patients: relation to disease activity. Egypt Rheumatol. 2017;39:171\u20134. https:\/\/doi.org\/10.1016\/j.ejr.2016.11.001.","journal-title":"Egypt Rheumatol"},{"key":"1044_CR24","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.arcmed.2010.05.008","volume":"41","author":"SK Kim","year":"2010","unstructured":"Kim SK, Choe JY, Park SH, Lee SW, Lee GH, Chung WT. Increased insulin resistance and serum resistin in Korean patients with Beh\u00e7et\u2019s disease. Arch Med Res. 2010;41:269\u201374. https:\/\/doi.org\/10.1016\/j.arcmed.2010.05.008.","journal-title":"Arch Med Res"},{"key":"1044_CR25","doi-asserted-by":"publisher","first-page":"450","DOI":"10.5114\/ada.2016.63884","volume":"33","author":"I Erden","year":"2016","unstructured":"Erden I, U\u00e7ak H, Demir B, et al. Serum ghrelin levels in patients with Behcet\u2019s disease. Postepy Dermatol Alergol. 2016;33:450\u20136. https:\/\/doi.org\/10.5114\/ada.2016.63884.","journal-title":"Postepy Dermatol Alergol"},{"key":"1044_CR26","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1684\/ejd.2014.2397","volume":"24","author":"I Erden","year":"2014","unstructured":"Erden I, Demir B, U\u00e7ak H, Cicek D, Dertlio\u011flu SB, Aydin S. Serum salusin-\u03b1 and salusin-\u03b2 levels in patients with Behcet\u2019s disease. Eur J Dermatol. 2014;24:577\u201382. https:\/\/doi.org\/10.1684\/ejd.2014.2397.","journal-title":"Eur J Dermatol"},{"key":"1044_CR27","unstructured":"Ula\u015fo\u011flu C. Frequency of metabolic syndrome and nonalcoholic fatty liver in Beh\u00e7et\u2019s disease 2013"},{"key":"1044_CR28","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1111\/jocd.14276","volume":"21","author":"F Cebeci Kahraman","year":"2022","unstructured":"Cebeci Kahraman F, Kayata\u015f K, Sava\u015f Erdo\u011fan S, Onsun N. Do nonobese patients with Beh\u00e7et\u2019s disease have insulin resistance? J Cosmet Dermatol. 2022;21:1688\u201394. https:\/\/doi.org\/10.1111\/jocd.14276.","journal-title":"J Cosmet Dermatol"},{"key":"1044_CR29","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/j.1468-3083.2006.01457.x","volume":"20","author":"H Erdem","year":"2006","unstructured":"Erdem H, Dinc A, Pay S, Simsek I, Turan M. Peripheral insulin resistance in patients with Beh\u00e7et\u2019s disease. J Eur Acad Dermatol Venereol. 2006;20:391\u20135. https:\/\/doi.org\/10.1111\/j.1468-3083.2006.01457.x.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1044_CR30","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1159\/000514634","volume":"238","author":"JH Jung","year":"2022","unstructured":"Jung JH, Han KD, Lee YB, Park YG. Beh\u00e7et\u2019s disease is associated with multiple sclerosis and rheumatoid arthritis: A Korean population-based study. Dermatology. 2022;238:86\u201391. https:\/\/doi.org\/10.1159\/000514634.","journal-title":"Dermatology"},{"key":"1044_CR31","doi-asserted-by":"publisher","first-page":"113","DOI":"10.5152\/eurjrheum.2017.160095","volume":"4","author":"SS Koca","year":"2017","unstructured":"Koca SS, Kara M, \u00d6zgen M, et al. Low prevalence of obesity in Beh\u00e7et\u2019s disease is associated with high obestatin level. Eur J Rheumatol. 2017;4:113\u20137. https:\/\/doi.org\/10.5152\/eurjrheum.2017.160095.","journal-title":"Eur J Rheumatol"},{"key":"1044_CR32","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s13075-021-02543-6","volume":"23","author":"CY Lin","year":"2021","unstructured":"Lin CY, Chen HA, Wu CH, Su YJ, Hsu TC, Hsu CY. Is Beh\u00e7et\u2019s syndrome associated with an increased risk of ischemic heart disease? A real-world evidence in Taiwan. Arthritis Res Ther. 2021;23:161. https:\/\/doi.org\/10.1186\/s13075-021-02543-6.","journal-title":"Arthritis Res Ther"},{"key":"1044_CR33","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.arcmed.2011.08.006","volume":"42","author":"M Messedi","year":"2011","unstructured":"Messedi M, Frigui M, Ben Mahfoudh K, et al. Intima-media thickness of carotid artery in patients with Beh\u00e7et\u2019s disease. Arch Med Res. 2011;42:398\u2013404. https:\/\/doi.org\/10.1016\/j.arcmed.2011.08.006.","journal-title":"Arch Med Res"},{"key":"1044_CR34","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1177\/0003319717704748","volume":"69","author":"N Acikgoz","year":"2018","unstructured":"Acikgoz N, Kurto\u011flu E, Yagmur J, Kapicioglu Y, Cansel M, Ermis N. Elevated monocyte to high-density lipoprotein cholesterol ratio and endothelial dysfunction in Beh\u00e7et disease. Angiology. 2018;69:65\u201370. https:\/\/doi.org\/10.1177\/0003319717704748.","journal-title":"Angiology"},{"key":"1044_CR35","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3233\/CH-2012-1564","volume":"54","author":"JM Ricart","year":"2013","unstructured":"Ricart JM, Espa\u00f1a F, Navarro S, Todol\u00ed J, De la Fuente JM, Vay\u00e1 A. Mean platelet volume does not seem to relate to thrombosis or posterior uveitis in Beh\u00e7et\u2019s disease. Clin Hemorheol Microcirc. 2013;54:51\u20137. https:\/\/doi.org\/10.3233\/CH-2012-1564.","journal-title":"Clin Hemorheol Microcirc"},{"key":"1044_CR36","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1093\/rheumatology\/kem385","volume":"47","author":"S Ugurlu","year":"2008","unstructured":"Ugurlu S, Seyahi E, Yazici H. Prevalence of angina, myocardial infarction and intermittent claudication assessed by Rose Questionnaire among patients with Behcet\u2019s syndrome. Rheumatology (Oxford). 2008;47:472\u20135. https:\/\/doi.org\/10.1093\/rheumatology\/kem385.","journal-title":"Rheumatology (Oxford)"},{"key":"1044_CR37","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ijcard.2017.02.135","volume":"241","author":"Y Yavne","year":"2017","unstructured":"Yavne Y, Tiosano S, Watad A, Comaneshter D, Cohen AD, Amital H. Investigating the link between ischemic heart disease and Behcet\u2019s disease: a cross-sectional analysis. Int J Cardiol. 2017;241:41\u20135. https:\/\/doi.org\/10.1016\/j.ijcard.2017.02.135.","journal-title":"Int J Cardiol"},{"key":"1044_CR38","doi-asserted-by":"publisher","DOI":"10.2174\/1573397118666220610123242","author":"SS Eladle","year":"2022","unstructured":"Eladle SS, Latif EA, Abdel-Fattah YH, et al. Metabolic syndrome in Beh\u00e7ets disease patients: keep an eye on the eye. Curr Rheumatol Rev. 2022. https:\/\/doi.org\/10.2174\/1573397118666220610123242.","journal-title":"Curr Rheumatol Rev"},{"key":"1044_CR39","doi-asserted-by":"publisher","unstructured":"Chen YY, Lai YJ, Yen YF, Chen HH, Chou P. Uveitis as a potential predictor of acute myocardial infarction in patients with Behcet\u2019s disease: a population-based cohort study. BMJ Open. 2021;11:e042201. https:\/\/doi.org\/10.1136\/bmjopen-2020-042201","DOI":"10.1136\/bmjopen-2020-042201"},{"key":"1044_CR40","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1111\/1346-8138.15809","volume":"48","author":"J Lee","year":"2021","unstructured":"Lee J, Yoo S, Han KD, et al. Association between metabolic syndrome and Beh\u00e7et\u2019s disease: a nationwide population-based study. J Dermatol. 2021;48:1062\u20136. https:\/\/doi.org\/10.1111\/1346-8138.15809.","journal-title":"J Dermatol"},{"key":"1044_CR41","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1007\/s10067-019-04570-w","volume":"38","author":"TA Gheita","year":"2019","unstructured":"Gheita TA, El-Latif EA, El-Gazzar II, et al. Beh\u00e7et\u2019s disease in Egypt: a multicenter nationwide study on 1526 adult patients and review of the literature. Clin Rheumatol. 2019;38:2565\u201375. https:\/\/doi.org\/10.1007\/s10067-019-04570-w.","journal-title":"Clin Rheumatol"},{"key":"1044_CR42","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1159\/000365139","volume":"129","author":"A Pandey","year":"2014","unstructured":"Pandey A, Garg J, Krishnamoorthy P, et al. Predictors of coronary artery disease in patients with Beh\u00e7et\u2019s disease. Cardiology. 2014;129:203\u20136. https:\/\/doi.org\/10.1159\/000365139.","journal-title":"Cardiology"},{"key":"1044_CR43","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3389\/fimmu.2019.00665","volume":"10","author":"B Tong","year":"2019","unstructured":"Tong B, Liu X, Xiao J, Su G. Immunopathogenesis of Behcet\u2019s disease. Front Immunol. 2019;10:665. https:\/\/doi.org\/10.3389\/fimmu.2019.00665.","journal-title":"Front Immunol"},{"key":"1044_CR44","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1177\/1753944717711379","volume":"11","author":"Y Rochlani","year":"2017","unstructured":"Rochlani Y, Pothineni NV, Kovelamudi S, Mehta JL. Metabolic syndrome: pathophysiology, management, and modulation by natural compounds. Ther Adv Cardiovasc Dis. 2017;11:215\u201325. https:\/\/doi.org\/10.1177\/1753944717711379.","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"1044_CR45","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.cmet.2012.04.001","volume":"15","author":"CK Glass","year":"2012","unstructured":"Glass CK, Olefsky JM. Inflammation and lipid signaling in the etiology of insulin resistance. Cell Metab. 2012;15:635\u201345. https:\/\/doi.org\/10.1016\/j.cmet.2012.04.001.","journal-title":"Cell Metab"},{"key":"1044_CR46","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.diabet.2011.11.006","volume":"38","author":"MC Calle","year":"2012","unstructured":"Calle MC, Fernandez ML. Inflammation and type 2 diabetes. Diabetes Metab. 2012;38:183\u201391. https:\/\/doi.org\/10.1016\/j.diabet.2011.11.006.","journal-title":"Diabetes Metab"},{"key":"1044_CR47","first-page":"158","volume":"49","author":"A Agita","year":"2017","unstructured":"Agita A, Alsagaff MT. Inflammation, immunity, and hypertension. Acta Med Indones. 2017;49:158\u201365.","journal-title":"Acta Med Indones"},{"key":"1044_CR48","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1002\/msc.1632","volume":"20","author":"G El Hasbani","year":"2022","unstructured":"El Hasbani G, Uthman I, Jawad S, Jawad ASM. The psychological impact of Beh\u00e7et\u2019s disease. Musculoskelet Care. 2022;20:742\u201357. https:\/\/doi.org\/10.1002\/msc.1632.","journal-title":"Musculoskelet Care"},{"key":"1044_CR49","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.eurpsy.2019.04.008","volume":"60","author":"M Rivera","year":"2019","unstructured":"Rivera M, Porras-Segovia A, Rovira P, Molina E, Guti\u00e9rrez B, Cervilla J. Associations of major depressive disorder with chronic physical conditions, obesity and medication use: results from the PISMA-ep study. Eur Psychiatry. 2019;60:20\u20137. https:\/\/doi.org\/10.1016\/j.eurpsy.2019.04.008.","journal-title":"Eur Psychiatry"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-023-01044-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-023-01044-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-023-01044-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T13:19:01Z","timestamp":1696079941000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-023-01044-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,20]]},"references-count":49,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["1044"],"URL":"https:\/\/doi.org\/10.1007\/s10238-023-01044-x","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,20]]},"assertion":[{"value":"8 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All analyses were based on previous published studies. Thus, no ethical approval and patient consent are required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}